RxDoctor Payments Data

Iraj Rueda

Family · Miami Beach, FLNPI 1639992308

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations.

$1,338in general payments, 2019–2025

Across 59 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$162
  • Incyte Corporation$141
  • Takeda Pharmaceuticals U.S.A., Inc.$124
  • Tersera Therapeutics LLC$110
  • Sanofi$100
  • AstraZeneca$89
  • plus $613 from 19 others

What the payments were for

  • Food & beverage$1,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,338 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Miami Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →